Now available on demand. Sign up to view
Making a name in cancer immunotherapy
Originally aired; June 13, 2017
The successful approach of cancer immunotherapy—using the body’s own immune system to fight cancer—continues to push boundaries, provide new avenues for research and ultimately a new breed of candidates and technologies for the treatment of patients.
This webcast will bring a number of cancer immunotherapy companies working in the field together to present their technologies and explain how they are advancing progress within immuno-oncology. The approaches and technologies covered within the webcast will include: Bioclonics, differentiated bispecific antibody therapeutics; LAMP-Vax, a unique immunotherapy platform creating DNA-based vaccines; targeted radioimmunotherapies, antibodies delivering radioisotopes and a precision engineering platform IsoCode for predictive cell response.
The webcast will conclude with a live roundtable discussion and a Q&A session with the speakers for you the audience to put your own questions to them.